Please select the option that best describes you:
How will the findings from the recent BOSS study affect your management of Barrett's esophagus without dysplasia?
Will you change your surveillance interval?
Answer from: at Academic Institution
The findings of the BOSS study are consistent with emerging data suggesting that the risk associated with nondysplastic Barrett’s esophagus (NDBE) is lower than previously estimated and that routine surveillance may not meaningfully alter clinical outcomes. Compared to symptom-driven (“at-needâ€...
Sign in or Register to read more